MARKET

MEDXF

MEDXF

Medexus Pharmace
OTCQX
2.950
+0.020
+0.68%
Closed 14:31 05/15 EDT
OPEN
2.950
PREV CLOSE
2.930
HIGH
2.950
LOW
2.950
VOLUME
300
TURNOVER
885
52 WEEK HIGH
3.020
52 WEEK LOW
1.850
MARKET CAP
59.41M
P/E (TTM)
-280.9524
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MEDXF last week (0504-0508)?
Weekly Report · 6d ago
Weekly Report: what happened at MEDXF last week (0427-0501)?
Weekly Report · 05/04 10:02
Weekly Report: what happened at MEDXF last week (0420-0424)?
Weekly Report · 04/27 10:04
Weekly Report: what happened at MEDXF last week (0413-0417)?
Weekly Report · 04/20 10:00
Medexus Provides Business Update on GRAFAPEX (treosulfan) for Injection, Capital Allocation, and Investor Conference Participation
Newsfile · 04/15 21:30
Weekly Report: what happened at MEDXF last week (0406-0410)?
Weekly Report · 04/13 10:03
Weekly Report: what happened at MEDXF last week (0330-0403)?
Weekly Report · 04/06 10:04
Weekly Report: what happened at MEDXF last week (0323-0327)?
Weekly Report · 03/30 10:04
More
About MEDXF
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. Its focus is on the therapeutic areas of hematology-oncology and allergy, dermatology, and rheumatology. It operates through two product portfolios: Medexus Pharma Canada and Medexus Pharma. Its lead products are IXINITY (US), GRAFAPEX (US), Trecondyv (Canada), Rupall (Canada), Rasuvo (US), Metoject (Canada), and Gleolan (US). IXINITY (US) is an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B. Rupall (Canada) is a prescription allergy medication with a mode of action. Rasuvo (US) and Metoject (Canada) is a formulation of methotrexate designed to treat rheumatoid arthritis and other autoimmune diseases. Gleolan (US) is an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery.

Webull offers Medexus Pharmaceuticals Inc stock information, including OTCQX: MEDXF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDXF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MEDXF stock methods without spending real money on the virtual paper trading platform.